Agile Therapeutics, Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/605297db-07ef-40f1-b5f3-e54e8cd2220a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-19.9M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004262 |
| FY 2022 | $-52.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004386 |
| FY 2021 | $-71.0M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004758 |
| FY 2020 | $-49.1M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002163 |
| FY 2019 | $-18.9M | 2019-01-01 – 2019-12-31 | evidence 0001047469-20-000966 |
| FY 2018 | $-19.5M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-001136 |
| FY 2017 | $-26.8M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001539 |
| FY 2016 | $-29.7M | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-001623 |
| FY 2015 | $-33.1M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010929 |
| FY 2014 | $-18.5M | 2014-01-01 – 2014-12-31 | evidence 0001047469-16-010929 |
| FY 2013 | $-12.7M | 2013-01-01 – 2013-12-31 | evidence 0001047469-16-010929 |
| FY 2012 | $-23.3M | 2012-01-01 – 2012-12-31 | evidence 0001047469-15-002798 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).